These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15961207)

  • 1. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity.
    Jongsma ME; Bosker FJ; Cremers TI; Westerink BH; den Boer JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):738-44. PubMed ID: 15961207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):89-94. PubMed ID: 12595948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Muraki I; Inoue T; Koyama T
    Eur J Pharmacol; 2008 May; 586(1-3):171-8. PubMed ID: 18423441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
    Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C; Hjorth S; Auerbach SB
    Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.
    Newman ME; Gur E; Dremencov E; Garcia F; Lerer B; Van de Kar LD
    Neuropharmacology; 2000 Sep; 39(12):2309-17. PubMed ID: 10974314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1-adrenoceptors modulate citalopram-induced serotonin release.
    Rea K; Folgering J; Westerink BH; Cremers TI
    Neuropharmacology; 2010 Jun; 58(7):962-71. PubMed ID: 20043931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
    Roberts C; Belenguer A; Middlemiss DN; Routledge C
    Eur J Pharmacol; 1998 Apr; 346(2-3):175-80. PubMed ID: 9652357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
    Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.